Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection
Sokhela et al., Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkac266
https://c19early.org/sokhela.html